LeonaBio (LONA) Change in Cash (2019 - 2026)
LeonaBio's (LONA) quarterly Change in Cash came in at -$36.4 million in Q1 2026, down 65.53% year-on-year from -$105.7 million in Q1 2025, and down 175.29% on a QoQ basis from $48.4 million in Q4 2025.
LeonaBio (LONA) Change in Cash (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 8 years of Change in Cash data on file, last reported at -$36.4 million in Q1 2026.
- On a quarterly basis, Change in Cash fell 65.53% year-over-year to -$36.4 million in Q1 2026; TTM through Mar 2026 was $6.4 million, a 112.47% increase from a year earlier, with the FY2025 full-year figure at $20.8 million, up 149.44% from the prior year.
- Change in Cash for Q1 2026 stood at -$36.4 million, down from $48.4 million in the prior quarter.
- Over the last five years, Change in Cash for LONA reached as high as $48.4 million in Q4 2025 and fell as low as -$36.4 million in Q1 2026.
- Historically, Change in Cash has averaged -$4.5 million across 5 years, with a median of -$5.0 million in 2024.
- Across the five-year window, Change in Cash sank 686.75% in 2022 and surged 268.12% in 2025, its largest moves.
- Year by year, Change in Cash stood at $9.1 million in 2022, then tumbled by 316.39% to -$19.8 million in 2023, then slumped by 45.78% to -$28.8 million in 2024, then jumped by 268.12% to $48.4 million in 2025, then plunged by 175.29% to -$36.4 million in 2026.
- Per Business Quant data, the three most recent Change in Cash figures were -$36.4 million in Q1 2026, $48.4 million in Q4 2025, and $986000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 243.78 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 57.19 Mn |
| 10 | LeonaBio | 138.33 Mn | 70.65 Mn | - | -36.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.44 Mn |
| Dec 31, 2025 | 48.40 Mn |
| Sep 30, 2025 | 986,000.00 |
| Jun 30, 2025 | -6.53 Mn |
| Mar 31, 2025 | -22.02 Mn |
| Dec 31, 2024 | -28.79 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Jun 30, 2024 | 4.38 Mn |
| Mar 31, 2024 | -12.76 Mn |
| Dec 31, 2023 | -19.75 Mn |
| Sep 30, 2023 | -3.29 Mn |
| Jun 30, 2023 | 8.45 Mn |
| Mar 31, 2023 | 9.43 Mn |
| Dec 31, 2022 | 9.13 Mn |
| Sep 30, 2022 | -8.01 Mn |
| Jun 30, 2022 | -22.75 Mn |
| Mar 31, 2022 | 7.48 Mn |
| Dec 31, 2021 | 3.21 Mn |
| Sep 30, 2021 | -24.37 Mn |
| Jun 30, 2021 | 3.88 Mn |